Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical

Details for Australian Patent Application No. 2002250920 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Strobel, Hartmut; Wohlfart, Paulus

Agent Watermark

Pub. Number AU-B-2002250920

PCT Pub. Number WO2002/064565

Priority 01102851.1 13.02.01 EP

Filing date 12 February 2002

Wipo publication date 28 August 2002

Acceptance publication date 28 June 2007

International Classifications

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 9/02 (2006.01) Medicinal preparations characterised by special physical form - Suppositories

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/404 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4184 (2006.01)

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4365 (2006.01)

A61K 31/4436 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/4965 - Non-condensed pyrazines

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002250920

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

28 June 2007 Application Accepted

  Published as AU-B-2002250920

25 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002250921-BINOCULAR OPTICAL DEVICE, IN PARTICULAR ELECTRONIC SPECTACLES, COMPRISING AN ELECTRONIC CAMERA FOR AUTOMATICALLY SETTING A FOCUS THAT INCLUDES THE CORRECTION OF DIFFERENT VISION DEFECTS

2002250919-CIGARETTE PACKET